Amateur boxers, specifically those who boxed during their youth, are twice as likely to develop Alzheimer's disease than those who didn't.
The form in which isomers take can increase the risk of developing dementia, researchers report. Drugs in development to improve autophagy may help prevents Alzheimer's from developing.
Physical activity appears to reduce microglial activation and improve cognition in the aging human brain, researchers report.
A new framework reveals Alzheimer's disease is far more complex than previously believed. Rather than being a disease where the same causes produce the same outcomes, researchers found three different models for the disease, each with its own characterizations and dynamics.
Findings suggest people with moderate Alzheimer's disease perform better at daily tasks when surrounded by their usual clutter.
A class of drugs called BACE1 inhibitors, originally designed to treat Alzheimer's disease, shows potential for the treatment of glioblastoma brain cancer.
Amyloid-beta accumulation in the brain may contribute to deficits in circadian regulation of learning and memory during the early stages of Alzheimer's disease.
A new brain model explored bursts of human brain activity never before studied. The bursts may serve as potential biomarkers for depression, dementia, schizophrenia, and ADHD.
People who drink between 4 - 6 cups of coffee or tea per day have a lower risk of stroke and dementia, researchers report. Drinking coffee alone, or in combination with tea, was associated with lower risk of post-stroke dementia.
A newly developed antibody-based treatment and protein-based vaccine reduced Alzheimer's symptoms in mouse models, researchers report.
A new neuro-optics technique can manipulate memory consolidation in mouse models by hindering long-term potentiation. Researchers say eliminating local LTP in the hippocampus erased memories. The method could be used to isolate memory formation at the cellular level.
Dasatinib, an FDA-approved drug for chronic myeloid leukemia, and an experimental drug for liver cancer reduced neuroinflammation, tau phosphorylation, and amyloid secretion in cell cultures of post-mortem brain samples of those with the APOE4 Alzheimer's associated gene.
